*Latest Investment Research* - Valuentum Securities Inc.

Use the drop down menu below to subscribe.

----------

At Valuentum, we follow hundreds of stocks and dividends. We serve individual investors, financial advisers, and institutions. Join Today! You'll gain immediate access to our premium product and service offering (including articles, commentary, stock reports, dividend reports, and more). You'll also receive the Best Ideas Newsletter and Dividend Growth Newsletter in your inbox every month. You can also order our ultra-premium publications, the High Yield Dividend Newsletter and the Exclusive publication, too!

Recent articles

Shares of UnitedHealth Group and Vertex Pharma Sour Dec 19, 2024: Image Source: Rodrigo Senna cc by 2.0.

As of right now, we continue to monitor the situation with UnitedHealth, but the risks have substantially increased. We have no plans to remove it from the Best Ideas Newsletter portfolio at this time as we await news flow to settle down. As for Vertex, we continue to like its established position in cystic fibrosis and its opportunity in gene-editing therapies as well as a new class of medicine for acute pain that’s without the limitations of opioids. Though the news regarding suzetrigine wasn’t what the market was hoping for, the company’s pipeline is progressing nicely.

View Current and Archived Best Ideas Newsletters: View previous editions of the Best Ideas Newsletter in this article.

Valuentum's Best Ideas Newsletter Portfolio Dec 15, 2024: We disclose the holdings of the portfolio of the Best Ideas Newsletter in this article. This portfolio can always be found in each edition of the monthly Best Ideas Newsletter.

Dividend Increases/Decreases for the Week of December 13 Dec 13, 2024: Let's take a look at firms raising/lowering their dividends this week.